Eli Lilly Share Buybacks increased by 56.3% to $2.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 96.3%, from $1.20B to $2.36B. Over 2 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 81.3% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $500.00M | $0.00 | $750.00M | $1.50B | $750.00M | $0.00 | $0.00 | $446.10M | $2.05B | $1.20B | $692.20M | $708.10M | $1.51B | $2.36B |
| QoQ Change | — | -100.0% | — | +100.0% | -50.0% | -100.0% | — | — | +360.4% | -41.6% | -42.3% | +2.3% | +112.9% | +56.3% |
| YoY Change | — | — | — | — | -50.0% | -100.0% | — | — | — | — | — | +58.7% | -26.6% | +96.3% |